COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,970 Articles (22,604 medRxiv, 8,366 bioRxiv)

Most recent first Previous |  Page 2985: Articles 29841-29850  | Next

The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin
Chorin, E., Dai, M., Shulman, E., Wadhwani, L., Bar Cohen, R., Barbhaiya, C., Aizer, A., Holmes, D., Bernstein, S., Soinelli, M., Park, D. S., Chinitz, L., Jankelosn, L.
10.1101/2020.04.02.20047050 — Posted: 2020-04-03 Discussion: Onsite
Interleukin-6 in COVID-19: A Systematic Review and Meta-Analysis
Coomes, E. A., Haghbayan, H.
10.1101/2020.03.30.20048058 — Posted: 2020-04-03
A flexible load sharing system and implementation to anticipate and organise transfers based on ICU demand in the context of COVID-19 pandemic
Lacasa, L., Challen, R., Brooks-Pollock, E., Danon, L.
10.1101/2020.03.31.20049239 — Posted: 2020-04-03
COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes
Khan, M. M. A., Khan, M. N., Mustagir, M. G., Rana, J., Haque, M. R., Rahman, M. M.
10.1101/2020.03.31.20049304 — Posted: 2020-04-03
Globalized low-income countries may experience higher COVID-19 mortality rates
Jaffe, R., Ortiz Vera, M. P., Jaffe, K.
10.1101/2020.03.31.20049122 — Posted: 2020-04-03
Clinical features, Diagnosis, and Treatment of COVID-19: A systematic review of case reports and case series
Tahvildari, A., Arbabi, M., Farsi, Y., Jamshidi, P., Hasanzadeh, S., Calcagno, T. M., Nasiri, M. J., Mirsaeidi, M.
10.1101/2020.03.28.20046151 — Posted: 2020-04-03
Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information - an essential step to facilitate decision making
von Cube, M., Grodd, M., Wolkewitz, M., Hazard, D., Lambert, J.
10.1101/2020.03.31.20049007 — Posted: 2020-04-03
Spatial variability in the risk of death from COVID-19 in Italy, 2020
Mizumoto, K., Dahal, S., Chowell, G.
10.1101/2020.04.01.20049668 — Posted: 2020-04-03 Discussion: Onsite
Japanese citizens' behavioral changes and preparedness against COVID-19: How effective is Japan's approach of self-restraint?
Muto, K., Yamamoto, I., Nagasu, M., Tanaka, M., Wada, K.
10.1101/2020.03.31.20048876 — Posted: 2020-04-03
Reply to Gautret et al. 2020: A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19
Hulme, O. J., Wagenmakers, E.-J., Damkier, P., Madelung, C. F., Siebner, H. R., Helweg-Larsen, J., Gronau, Q., Benfield, T. L., Madsen, K. H.
10.1101/2020.03.31.20048777 — Posted: 2020-04-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).